Vertex taps BMS talent to head commercial activities outside US

CANbridge Pharmaceuticals strengthens senior team
Credit: andia

Vertex Pharmaceuticals have appointed Ludovic Fenaux as Senior Vice President, International Commercial Operations.

In his new role, Mr Fenaux will be responsible for commercial activities outside of the US and Canada.

He will oversee offices and operations across Europe, Australia and Latin America.

Based at the International headquarters in London, Mr Fenaux succeeds Simon Bedson, who is retiring after seven years as Vertex’s Senior Vice President and General Manager, International Commercial Operations.

Stuart Arbuckle, Executive Vice President and Chief Commercial Officer, Vertex, said: “Ludovic brings the leadership skills and functional and geographic experience our growing international organisation needs as we become a leading global biotechnology company.”

Mr Fenaux joins with more than two decades of pharma industry experience, most recently at Bristol-Myers Squibb where he held the position of Senior Vice President, Head of Intercontinental Region.